Liver Cirrhosis

"Liver Cirrhosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.

Descriptor ID	D008103
MeSH Number(s)	C06.552.630
Concept/Terms	Liver Cirrhosis Liver Cirrhosis Cirrhosis, Liver Cirrhoses, Liver Liver Cirrhoses Hepatic Cirrhosis Cirrhoses, Hepatic Cirrhosis, Hepatic Hepatic Cirrhoses Fibrosis, Liver Fibrosis, Liver Fibroses, Liver Liver Fibroses Liver Fibrosis

Below are MeSH descriptors whose meaning is more general than "Liver Cirrhosis".

Diseases [C]
Digestive System Diseases [C06]
Liver Diseases [C06.552]
Liver Cirrhosis [C06.552.630]

Below are MeSH descriptors whose meaning is more specific than "Liver Cirrhosis".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Liver Cirrhosis" by people in this website by year, and whether "Liver Cirrhosis" was a major or minor topic of these publications.

Bar chart showing 52 publications over 22 distinct years, with a maximum of 6 publications in 2023

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1999	0	1	1
2002	1	0	1
2003	1	2	3
2005	1	0	1
2006	1	1	2
2007	1	0	1
2008	0	1	1
2009	1	0	1
2011	1	1	2
2013	1	1	2
2014	0	3	3
2015	2	2	4
2016	2	0	2
2017	3	1	4
2018	2	0	2
2019	1	1	2
2020	3	1	4
2021	2	1	3
2022	1	1	2
2023	1	5	6
2024	1	1	2
2025	2	1	3

Below are the most recent publications written about "Liver Cirrhosis" by people in Profiles.

Saleem S, Sajid MS, Varghese RS, Sherif ZA, Kroemer A, Ressom HW. Phosphopeptidome Profiling of Human Plasma for Hepatocellular Carcinoma Biomarker Discovery. J Proteome Res. 2026 Feb 06; 25(2):1115-1125.

View in: PubMed
Nara A, Shimada S, Akiyama Y, Hatano M, Chino Y, Miyazawa S, Tamura H, Asano D, Ishikawa Y, Ueda H, Watanabe S, Katsuta E, Akahoshi K, Ohashi K, Tanabe M, Ban D, Tanaka S. Targeting SPP1-CD44-Hedgehog Axis Elicits Therapeutic Effects in Hepatocellular Carcinoma by Suppressing Intratumoral Fibrosis. Cancer Sci. 2026 Mar; 117(3):670-682.

View in: PubMed
He AR, Smith CI, Cruz-Correa M, Chakraborty R, Zhang S, Sang S, Cheng G, Hecht SS, Bazzi LA, Kocherginsky M, Benante KA, Schering T, Richmond E, Rodriguez LM, Khan SA, Chung FL. A Phase I Dose-Escalation Study of Polyphenon E in Liver Cirrhosis: Evaluation of Safety and Effect on Liver ?-OHPdG Levels. Cancer Prev Res (Phila). 2025 Oct 01; 18(10):635-646.

View in: PubMed
Yamada A, Watanabe A, Nara A, Ishimaru N, Maeda K, Ido Y, Kotake K, Asano M, Shinohara Y, Yamamoto T. Longitudinal Analysis of Mitochondrial Function in a Choline-Deficient L-Amino Acid-Defined High-Fat Diet-Induced Metabolic Dysfunction-Associated Steatohepatitis Mouse Model. Int J Mol Sci. 2024 Jun 04; 25(11).

View in: PubMed
Diwan R, Gaytan SL, Bhatt HN, Pena-Zacarias J, Nurunnabi M. Liver fibrosis pathologies and potentials of RNA based therapeutics modalities. Drug Deliv Transl Res. 2024 10; 14(10):2743-2770.

View in: PubMed
Bangaru S, Sundaresh R, Lee A, Prause N, Hao F, Dong TS, Tincopa M, Cholankeril G, Rich NE, Kawamoto J, Bhattacharya D, Han SB, Patel AA, Shaheen M, Benhammou JN. Predictive Algorithm for Hepatic Steatosis Detection Using Elastography Data in the Veterans Affairs Electronic Health Records. Dig Dis Sci. 2023 12; 68(12):4474-4484.

View in: PubMed
Kanwal F, Nelson R, Liu Y, Kramer JR, Hernaez R, Cholankeril G, Rana A, Flores A, Smith D, Cao Y, Beech B, Asch SM. Cost of Care for Patients With Cirrhosis. Am J Gastroenterol. 2024 03 01; 119(3):497-504.

View in: PubMed
Hang Y, Lee C, Roman YM. Assessing the clinical utility of major indices for nonalcoholic fatty liver disease in East?Asian populations. Biomark Med. 2023 04; 17(8):445-454.

View in: PubMed
Pan CC, Maeso-D?az R, Lewis TR, Xiang K, Tan L, Liang Y, Wang L, Yang F, Yin T, Wang C, Du K, Oh SH, Wang E, Lim BJW, Chong M, Alexander PB, Yao X, Arshavsky VY, Li QJ, Diehl AM, Wang XF. Antagonizing the irreversible thrombomodulin-initiated proteolytic signaling alleviates age-related liver fibrosis via senescent cell killing. Cell Res. 2023 07; 33(7):516-532.

View in: PubMed
Makrogiannis S. Editorial for "Diagnosis of Sarcopenia Using the L3 Skeletal Muscle Index Estimated from the L1 Skeletal Muscle Index on MR Images in Patients With Cirrhosis". J Magn Reson Imaging. 2023 11; 58(5):1579.

View in: PubMed

People

Explore

Similar Concepts

Top Journals